1. Home
  2. HYNE vs BHST Comparison

HYNE vs BHST Comparison

Compare HYNE & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

HYNE

Hoyne Bancorp Inc.

N/A

Current Price

$15.69

Market Cap

116.5M

Sector

Finance

ML Signal

N/A

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$4.14

Market Cap

97.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYNE
BHST
Founded
2025
2007
Country
United States
Canada
Employees
N/A
87
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
116.5M
97.7M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HYNE
BHST
Price
$15.69
$4.14
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
15.9K
29.9K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$146.27
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.56
$4.10
52 Week High
$16.14
$12.80

Technical Indicators

Market Signals
Indicator
HYNE
BHST
Relative Strength Index (RSI) 54.87 41.45
Support Level $15.49 $4.10
Resistance Level N/A $4.54
Average True Range (ATR) 0.23 0.14
MACD -0.06 -0.01
Stochastic Oscillator 37.25 13.64

Price Performance

Historical Comparison
HYNE
BHST

About HYNE Hoyne Bancorp Inc.

Hoyne Bancorp Inc is a holding company that conducts business mainly through its subsidiaries. It is a savings institution focused on serving customers' banking needs in the market area. The group offers Personal and Business banking services.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: